Guggenheim Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.47M Sell
10,649
-1,718
-14% -$560K 0.03% 513
2025
Q1
$3.34M Sell
12,367
-416
-3% -$112K 0.03% 516
2024
Q4
$3.01M Sell
12,783
-2,465
-16% -$580K 0.02% 537
2024
Q3
$4.19M Sell
15,248
-3,939
-21% -$1.08M 0.03% 584
2024
Q2
$4.66M Sell
19,187
-1,975
-9% -$480K 0.03% 544
2024
Q1
$3.16M Buy
21,162
+3,411
+19% +$510K 0.02% 728
2023
Q4
$3.4M Buy
17,751
+507
+3% +$97K 0.03% 664
2023
Q3
$3.05M Sell
17,244
-2,422
-12% -$429K 0.03% 664
2023
Q2
$3.74M Sell
19,666
-320
-2% -$60.8K 0.03% 631
2023
Q1
$4M Sell
19,986
-831
-4% -$166K 0.03% 603
2022
Q4
$4.95M Buy
20,817
+1,560
+8% +$371K 0.04% 532
2022
Q3
$3.85M Sell
19,257
-6,092
-24% -$1.22M 0.04% 592
2022
Q2
$3.7M Sell
25,349
-395
-2% -$57.6K 0.03% 665
2022
Q1
$4.2M Sell
25,744
-561
-2% -$91.6K 0.03% 714
2021
Q4
$4.46M Buy
26,305
+2,461
+10% +$417K 0.02% 728
2021
Q3
$4.5M Sell
23,844
-2,093
-8% -$395K 0.03% 704
2021
Q2
$4.4M Sell
25,937
-3,501
-12% -$594K 0.03% 722
2021
Q1
$4.16M Sell
29,438
-2,205
-7% -$311K 0.03% 710
2020
Q4
$4.11M Sell
31,643
-6,401
-17% -$832K 0.03% 666
2020
Q3
$5.54M Sell
38,044
-7,104
-16% -$1.03M 0.04% 485
2020
Q2
$6.69M Buy
45,148
+3,330
+8% +$493K 0.05% 401
2020
Q1
$4.55M Sell
41,818
-9,187
-18% -$1M 0.05% 476
2019
Q4
$5.87M Buy
51,005
+315
+0.6% +$36.3K 0.04% 540
2019
Q3
$4.08M Sell
50,690
-7,433
-13% -$598K 0.03% 685
2019
Q2
$4.22M Sell
58,123
-2,134
-4% -$155K 0.03% 696
2019
Q1
$5.63M Sell
60,257
-3,717
-6% -$347K 0.05% 549
2018
Q4
$4.66M Buy
63,974
+3,473
+6% +$253K 0.04% 607
2018
Q3
$5.3M Buy
60,501
+4,680
+8% +$410K 0.03% 690
2018
Q2
$5.5M Buy
55,821
+2,737
+5% +$270K 0.04% 656
2018
Q1
$6.32M Buy
53,084
+600
+1% +$71.5K 0.02% 882
2017
Q4
$6.67M Sell
52,484
-32,983
-39% -$4.19M 0.02% 884
2017
Q3
$10M Buy
85,467
+18,094
+27% +$2.13M 0.02% 679
2017
Q2
$5.38M Sell
67,373
-17,484
-21% -$1.39M 0.01% 975
2017
Q1
$4.35M Buy
84,857
+5,774
+7% +$296K 0.01% 1109
2016
Q4
$2.96M Buy
79,083
+4,565
+6% +$171K 0.01% 1379
2016
Q3
$5.05M Sell
74,518
-11,850
-14% -$803K 0.02% 1011
2016
Q2
$4.79M Sell
86,368
-4,294
-5% -$238K 0.02% 1028
2016
Q1
$5.69M Sell
90,662
-23,340
-20% -$1.47M 0.02% 920
2015
Q4
$10.7M Sell
114,002
-28,541
-20% -$2.69M 0.03% 733
2015
Q3
$11.5M Sell
142,543
-2,220
-2% -$178K 0.04% 700
2015
Q2
$17.4M Buy
144,763
+8,423
+6% +$1.01M 0.04% 642
2015
Q1
$14.2M Buy
136,340
+22,323
+20% +$2.33M 0.03% 722
2014
Q4
$11.1M Buy
114,017
+14,441
+15% +$1.4M 0.03% 801
2014
Q3
$7.78M Sell
99,576
-4,254
-4% -$332K 0.02% 990
2014
Q2
$6.56M Sell
103,830
-10,627
-9% -$671K 0.02% 1033
2014
Q1
$7.68M Buy
114,457
+13,710
+14% +$920K 0.02% 935
2013
Q4
$6.48M Sell
100,747
-7,349
-7% -$473K 0.02% 975
2013
Q3
$6.92M Sell
108,096
-73,320
-40% -$4.69M 0.02% 947
2013
Q2
$5.63M Buy
+181,416
New +$5.63M 0.02% 1000